Tue, December 6, 2022
Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022
Tue, November 29, 2022
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022

Douglas Tsao Initiated (VRDN) at Strong Buy and Held Target at $35 on, Dec 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-35-on-dec-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Tsao of HC Wainwright & Co., Initiated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $35 on, Dec 1st, 2022.

Douglas has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Douglas


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Tuesday, November 15th, 2022
  • Michael Higgins of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, August 16th, 2022
  • Mike Kratky of "SVB Leerink" Maintained at Buy with Increased Target to $40 on, Monday, August 15th, 2022

Publication Contributing Sources